Indeed, epidemiological studies revealed that NAFLD patients had considerably greater circulating fetuin-A levels than healthy controls, and elevated fetuin-A independently predicted the occurrence of NAFLD (8). The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.